Suppr超能文献

脓毒症休克和危重症 COVID-19 患者的细胞 NETosis 和核小体生物标志物:一项观察性研究。

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

机构信息

Research and Development Department, Qualiblood s.a., 5000 Namur, Belgium.

Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, Department of Pharmacy, University of Namur, 5000 Namur, Belgium.

出版信息

Biomolecules. 2022 Jul 27;12(8):1038. doi: 10.3390/biom12081038.

Abstract

Background: Neutrophil extracellular traps’ (NETs’) formation is a mechanism of defense that neutrophils deploy as an alternative to phagocytosis, to constrain the spread of microorganisms. Aim: The aim was to evaluate biomarkers of NETs’ formation in a patient cohort admitted to intensive care unit (ICU) due to infection. Methods: Forty-six septic shock patients, 22 critical COVID-19 patients and 48 matched control subjects were recruited. Intact nucleosomes containing histone 3.1 (Nu.H3.1), or citrullinated histone H3R8 (Nu.Cit-H3R8), free citrullinated histone (Cit-H3), neutrophil elastase (NE) and myeloperoxidase (MPO) were measured. Results: Significant differences in Nu.H3.1 and NE levels were observed between septic shock and critical COVID-19 subjects as well as with controls (p-values < 0.05). The normalization of nucleosome levels according to the neutrophil count improved the discrimination between septic shock and critical COVID-19 patients. The ratio of Nu.Cit-H3R8 to Nu.H3.1 allowed the determination of nucleosome citrullination degree, presumably by PAD4. Conclusions: H3.1 and Cit-H3R8 nucleosomes appear to be interesting markers of global cell death and neutrophil activation when combined. Nu.H3.1 permits the evaluation of disease severity and differs between septic shock and critical COVID-19 patients, reflecting two distinct potential pathological processes in these conditions.

摘要

背景

中性粒细胞胞外诱捕网(NETs)的形成是一种防御机制,中性粒细胞在吞噬作用之外使用这种机制来限制微生物的传播。目的:本研究旨在评估因感染而入住重症监护病房(ICU)的患者群体中 NETs 形成的生物标志物。方法:招募了 46 例脓毒症休克患者、22 例重症 COVID-19 患者和 48 例匹配的对照受试者。测定完整的核小体,包括组蛋白 3.1(Nu.H3.1)或瓜氨酸化组蛋白 H3R8(Nu.Cit-H3R8)、游离瓜氨酸化组蛋白(Cit-H3)、中性粒细胞弹性蛋白酶(NE)和髓过氧化物酶(MPO)。结果:脓毒症休克和重症 COVID-19 患者与对照组之间,Nu.H3.1 和 NE 水平存在显著差异(p 值均<0.05)。根据中性粒细胞计数对核小体水平进行归一化,可改善脓毒症休克和重症 COVID-19 患者之间的鉴别。Nu.Cit-H3R8 与 Nu.H3.1 的比值可确定核小体瓜氨酸化程度,推测是由 PAD4 所致。结论:当联合使用时,H3.1 和 Cit-H3R8 核小体似乎是细胞死亡和中性粒细胞激活的有趣标志物。Nu.H3.1 可评估疾病严重程度,且在脓毒症休克和重症 COVID-19 患者之间存在差异,反映了这两种情况下两种不同的潜在病理过程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验